The Role of Microbial Factors in Prostate Cancer Development-An Up-to-Date Review

被引:9
|
作者
Garbas, Karolina [1 ]
Zapala, Piotr [1 ]
Zapala, Lukasz [1 ]
Radziszewski, Piotr [1 ]
机构
[1] Med Univ Warsaw, Dept Gen Oncol & Funct Urol, Poland Lindleya 4, PL-02005 Warsaw, Poland
关键词
microbiome; microbiota; sexually transmitted infections; prostate cancer; SEXUALLY-TRANSMITTED INFECTIONS; RISK; PREVENTION; BACTERIA; MEN;
D O I
10.3390/jcm10204772
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Up-to-date studies emphasize the role of human urinary and intestinal microbiome in maintaining urogenital health. Both microbial flora and sexually transmitted pathogens may affect metabolic or immune mechanisms and consequently promote or inhibit prostate carcinogenesis. Hereby, we review the most current evidence regarding the microbial factors and their link to prostate cancer. We conducted a literature search up to December 2020. The microbial impact on prostate cancer initiation and progression is complex. The proposed mechanisms of action include induction of chronic inflammatory microenvironment (Propionibacterium spp., sexually-transmitted pathogens) and direct dysregulation of cell cycle (Helicobacter pylori, Kaposi's sarcoma-associated herpesvirus- KSHV, human papilloma virus 18- HPV18). Suppression of immune cell expression and downregulating immune-associated genes are also observed (Gardnerella vaginalis). Additionally, the impact of the gut microbiome proved relevant in promoting tumorigenesis (Bacteroides massiliensis). Nevertheless, certain microbes appear to possess anti-tumor properties (Listeria monocytogenes, Pseudomonas spp.), such as triggering a robust immune response and apoptotic cancer cell death. The role of microbial factors in prostate cancer development is an emerging field that merits further studies. In the future, translating microbial research into clinical action may prove helpful in predicting diagnosis and potential outcomes of the disease.</p>
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Radiomics in prostate cancer: an up-to-date review
    Ferro, Matteo
    de Cobelli, Ottavio
    Musi, Gennaro
    del Giudice, Francesco
    Carrieri, Giuseppe
    Busetto, Gian Maria
    Falagario, Ugo Giovanni
    Sciarra, Alessandro
    Maggi, Martina
    Crocetto, Felice
    Barone, Biagio
    Caputo, Vincenzo Francesco
    Marchioni, Michele
    Lucarelli, Giuseppe
    Imbimbo, Ciro
    Mistretta, Francesco Alessandro
    Luzzago, Stefano
    Vartolomei, Mihai Dorin
    Cormio, Luigi
    Autorino, Riccardo
    Tataru, Octavian Sabin
    THERAPEUTIC ADVANCES IN UROLOGY, 2022, 14
  • [2] The Contemporary Role of Salvage Radical Prostatectomy in the Management of Recurrent Prostate Cancer: An Up-to-Date Review
    Katsimperis, Stamatios
    Pinitas, Alexandros
    Zerva, Maria
    Bellos, Themistoklis
    Manolitsis, Ioannis
    Feretzakis, Georgios
    Verykios, Vassilios S.
    Kyriazis, Ioannis
    Neofytou, Panagiotis
    Kapsalos, Sotirios
    Deligiannis, Panagiotis
    Triantafyllou, Panagiotis
    Juliebo-Jones, Patrick
    Somani, Bhaskar
    Mitsogiannis, Iraklis
    Tzelves, Lazaros
    LIFE-BASEL, 2024, 14 (07):
  • [3] Up-to-Date Imaging and Diagnostic Techniques for Prostate Cancer: A Literature Review
    Zhu, Ming
    Liang, Zhen
    Feng, Tianrui
    Mai, Zhipeng
    Jin, Shijie
    Wu, Liyi
    Zhou, Huashan
    Chen, Yuliang
    Yan, Weigang
    DIAGNOSTICS, 2023, 13 (13)
  • [4] Up-to-date on the mechanism of castration resistance in prostate cancer
    Shiota, Masaki
    Eto, Masatoshi
    CANCER SCIENCE, 2018, 109 : 1221 - 1221
  • [5] An up-to-date evaluation of abiraterone for the treatment of prostate cancer
    Shpilsky, Jason
    Stevens, Julia
    Bubley, Glenn
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (10) : 1227 - 1234
  • [6] An up-to-date evaluation of darolutamide for the treatment of prostate cancer
    Moussa, Mohamad
    Lazarou, Lazaros
    Dellis, Athanasios
    Abou Chakra, Mohamed
    Papatsoris, Athanasios
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (04) : 397 - 402
  • [7] Evaluation of colon cancer prognostic factors by CT and MRI: an up-to-date review
    Guimaraes, Ruggeri B.
    Pacheco, Eduardo O.
    Ueda, Serli N.
    Tiferes, Dario A.
    Mazzucato, Fernanda L.
    Talans, Aley
    Torres, Ulysses S.
    D'Ippolito, Giuseppe
    ABDOMINAL RADIOLOGY, 2024, : 4003 - 4015
  • [8] An up-to-date catalogue of urinary markers for the management of prostate cancer
    Broenimann, Stephan
    Pradere, Benjamin
    Karakiewicz, Pierre
    Huebner, Nicolai A.
    Briganti, Alberto
    Shariat, Shahrokh F.
    CURRENT OPINION IN UROLOGY, 2020, 30 (05) : 684 - 688
  • [9] The application of aptamers in cancer research: an up-to-date review
    Hu, Meidi
    Zhang, Kunhe
    FUTURE ONCOLOGY, 2013, 9 (03) : 369 - 376
  • [10] Up-to-date role of aflibercept in the treatment of colorectal cancer
    Saoudi Gonzalez, Nadia
    Salva, Francesc
    Ros, Javier
    Baraibar, Iosune
    Marmolejo, David
    Valdivia, Augusto
    Luis Cuadra-Urteaga, Jose
    Mulet, Nuria
    Tabernero, Josep
    Elez, Elena
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (10) : 1315 - 1324